Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/02/22
End: 08/08/24
Due: 08/08/25
Phase: N/A
Priority: Normal
Start: 12/02/21
End: 08/09/24
Due: 08/09/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) | NCT05557942 | Aerovate Therapeutics | user2@example.com | None | 2022-11-02 | 2024-08-08 | 2025-08-08 | - | - | 2025-07-14 |
| A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) | NCT05036135 | Aerovate Therapeutics | user2@example.com | None | 2021-12-02 | 2024-08-09 | 2025-08-09 | - | - | 2025-07-14 |